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CASE REPORT
A 60-year-old man presented with cough, sputum, and dyspnea. He had a history of acute myeloid leukemia
and hematopoietic stem cell transplantation with chronic renal failure. Chest CT scans showed miliary nodules
and patchy consolidations. Histological examination revealed numerous fibrin balls within the alveoli and
thickening of the alveolar septum, both of which are typical pathological features of acute fibrinous and
organizing pneumonia (AFOP). We report the first case of AFOP following allogeneic hematopoietic stem cell
transplantation. (Korean J Intern Med 2009;24:156-159)
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INTRODUCTION
The incidences of hematopoietic stem cell transplan-
tation (HSCT) and graft-versus-host disease (GVHD) are
increasing. In particular, 40-60% of patients with HSCT
sometimes develop pulmonary complications, with the
incidence varying according to the type of transplant,
conditioning regimen, underlying disease, and age of the
patient. Pulmonary complications encompass various
noninfectious conditions, including pulmonary edema,
diffuse alveolar hemorrhage, idiopathic pneumonia
syndrome, bronchiolitis obliterans, and cryptogenic
organizing pneumonia (COP) [1]. There also exist unusual
histological patterns with predominantly intra-alveolar
fibrin and organizing pneumonia, which do not meet the
criteria for acute interstitial pneumonia or COP. Thus far,
there are only a few reports describing these findings [2-
4]. In this paper, we describe a case of intra-alveolar fibrin
and organizing pneumonia following allogeneic HSCT.
CASE REPORT
A 60-year-old man, who had no history of smoking, was
diagnosed with acute myeloid leukemia (FAB classifi-
cation M1) in February 2005. He was treated with
anthracyclin and cytarabine arabinoside for remission
induction and postremission therapy. During the first
remission induction period, he developed chemotherapy-
related pneumonia and sepsis for 21 days. At the second
induction chemotherapy, we confirmed a complete
remission through bone marrow biopsy and aspiration.
Next, we tested his sibling’s human leukocyte antigen
(HLA) in an attempt to find a stem cell donor. Completely
matched HLA (A, B, C, and DR) and ABO-matched blood
were detected in his 55-year-old sister. From his sister,
we collected the G-CSF-mobilized stem cells from
peripheral blood and harvested the bone marrow. The
total concentrations of the various components of the
harvested cells were as follows: total nuclear cells (TNCs),Lee SM, et al. Acute fibrinous and organizing pneumonia   157
19.48×10
8/recipient-kg; mononuclear cells (MNCs), 10.11
×10
8/kg; CD34 cells, 1.8×10
6/kg; and CD3 cells, 21.7×
10
7/kg. After nonmyeloabrative conditioning with
fludarabine (from day -9 to day -5; 25 mg/m
2/day
1) and
melphalan (from day -4 to day -3; 70 mg/m
2/day
1), the
patient underwent allogeneic HSCT with total harvested
cells in September 2005. He was treated with cyclosporine
A and short-term methotrexate for GVHD prophylaxis.
Pulmonary function test (PFT), including spirometry, lung
volume, diffusion, and airway resistance, performed
before the transplantation showed mild pulmonary
insufficiency of the mixed type with decreased cabon
monoxide diffusing capacity (DLCO). The patient also had
chronic renal failure that was treated with hemodialysis.
In November 2005, he complained of cough and dyspnea
due to pleural effusion, but the symptoms disappeared
after intensified hemodialysis and pleurodesis with talc. 
In January 2006, he again complained of cough,
sputum, and exertional dyspnea for 3 days. On physical
examination, the respiratory rate was 18/min and the
heart rate was 104 beats/min. However, there was no
fever, edema, or cyanosis. Auscultation revealed fine
inspiratory crackles in both lung bases. The C-reactive
protein level was 6.0 mg/dL (normal: ≤0.4 mg/dL);
erythrocyte sedimentation rate, 25 mm/h (normal: ≤9
mm/hours); and serum creatinine level, 4.4 mg/dL
(normal: ≤1.20 mg/dL). The white blood cell count was
5200× 10
3/µL (normal: 4,000-10,000×10
3/µL) with
normal differential counts; hemoglobin concentration, 7.9
g/dL (normal: 14-18 g/dL); and platelet count, 44×10
3/µL
(normal: 150-450×10
3/µL). Examination of arterial blood
gases in room air revealed a pH of 7.527, PaCO2 of 38.8
mmHg, and PaO2 of 72.2 mmHg. Both cytomegalovirus
and Pneumocystis carinii were found to be negative by
PCR of the bronchoalveolar lavage (BAL) fluid. BAL
was also negative for the markers of other infections.
Cryptogenic antigen was negative in the peripheral blood.
Bone marrow study showed no evidence of leukemic blast.
Chromosome analysis showed 46XX, and chimerism
analysis revealed complete chimerism. 
The initial chest radiograph demonstrated diffuse
haziness and miliary nodules in both the lungs and slight
right pleural effusion (Fig. 1). There were no significant
changes on chest radiographs after hemodialysis. High-
resolution chest CT (HRCT) scans showed diffuse miliary
nodules and ground glass opacity in both the lungs,
patchy consolidation in the left lower lobe, and pleural
effusion in the right lobe (Fig. 2). He had been on regular
dialysis and had not had any change of pleural effusion.
PFT findings worsened to extremely severe pulmonary in-
sufficiency of a restrictive type and moderately decreased
DLCO.
At admission day 4, transbronchial lung biopsy was
performed. All 6 biopsy specimens revealed similar
pathological findings. The specimens showed intra-
alveolar spaces containing fibrous plugging with extensive
fibrin deposition, a finding consistent with cryptogenic
organizing pneumonia with fibrous exudates (Fig. 3A).
Fibrin balls with hemosiderin deposition were noted
in the alveolar spaces (Fig. 3B). There was no evidence
of diffuse alveolar damage, alveolitis, eosinophilic
infiltration, or granulomas. Fibrin ball is a characteristic
Figure 1. The chest radiography. The initial chest radiograph
reveals diffuse haziness and miliary nodules in both the lungs and
slight right pleural effusion.
Figure 2. HRCT. HRCT scan shows diffuse miliary nodules and
ground glass opacity in both the lungs and pleural effusion in the right
lobe. Patchy consolidation in the left lower lobe can be noted on the CT
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finding of acute fibrinous and organizing pneumonia
(AFOP) and presents as dense and red coalescent masses
on hematoxylin-eosin (H&E) staining. There were no
histological features of uremic lung, including protein-rich
edema, vascular congestion, tuberculous infection, or
fungal infection. A course of broad-spectrum antibiotics
and methylprednisolone pulse therapy (60 mg/day) was
administered. At day 28 of the methylprednisolone
treatment (30 mg/day), ground opacity and military
nodules in both the lungs and right pleural effusion were
slightly decreased with concomitant improvement in his
respiratory symptoms and O2 saturation. At day 44 of the
methylprednisolone treatment, ground glass opacity
and miliary nodules in both the lungs increased, and the
PFT showed no change. Therefore, we increased the dose
of methylprednisolone to 45 mg/day. At day 61 of the
methylprednisolone treatment (20 mg/day), the patient
developed hemoptysis, for which we performed bronchial
angiography with embolization. After 3 days, he died due
to respiratory failure. 
DISCUSSION
AFOP was first reported by Beasley in 2002 as an un-
usual type of acute lung injury [2]. Progressive dyspnea
was the major symptom, with commonly accompanying
cough, fever, and chest pain. Thus far, there are only a few
reports describing AFOP [2-4]. This disease is charac-
terized by histological features comprising prominent
intraalveolar fibrin deposition (fibrin balls) and organizing
pneumonia [2]. Although its clinical and radiological
features have not been precisely defined, AFOP is presumed
to be a type of diffuse alveolar damage. It has been reported
that AFOP can either be idiopathic or occur in association
with a spectrum of clinical conditions, including collagen
vascular diseases, adverse drug or chemicals reactions,
lymphoma, altered immune status, and inhalation
diseases [2,3]. The present patient had a history of acute
myeloid leukemia with chronic renal failure. Histologically,
there was no evidence of uremic lung, which is char-
acterized by generalized protein-rich interstitial and
intraalveolar edema associated with the expansion of
parenchymal connective tissues and prominent lymphatic
duct ectasia [5]. Hemodialysis did not result in the
improvement of the lung lesions. These findings indicated
AFOP as the histological and clinical diagnosis in this
patient.
At admission, the HRCT scan revealed new patchy
consolidations in the left lower lobe and diffuse military
nodules in both the lungs. Accordingly, we suspected
miliary tuberculosis or disseminated fungal infection as
the diagnosis. These clinical and radiological findings
were similar to those described in the case report of
Kobayashi [4]. Beasley has described the radiological
features of 15 patients with AFOP: the most common
radiographic pattern was bilateral basilar infiltration,
and nodular lesions were not seen in any of the 15 patients
[2].
There appear to be 2 clinical presentations of AFOP.
One is the subacute type that resembles COP or bron-
chiolitis obliterans organizing pneumonia (BOOP) [6].
Figure 3. Microscopic findings of a lung specimen. (A) The biopsied lung shows intra-alveolar spaces containing fibrous plugging with
extensive fibrin deposition, a finding consistent with cryptogenic organizing pneumonia with fibrous exudates (H&E, ×100). (B) Fibrin balls
with hemosiderin deposition are noted in the alveolar spaces (H&E, ×200). 
A BLee SM, et al. Acute fibrinous and organizing pneumonia   159
In patients with COP or BOOP, a solitary nodule or
multiple nodules were detected radiologically. Akira
reported that 53 of 60 nodular lesions detected in 12
BOOP patients had an irregular margin, and 27 had an
air bronchogram. Therefore, he concluded that BOOP
should be considered when imaging reveals nodular
lesions with an air bronchogram and irregular margins
[7]. Thus, the first type of AFOP was reported to have
some clinical similarities with BOOP [8-10]. Corticosteroid
therapy resulted in the improvement of nodular lesions
and diffuse infiltrates. The disease in our patient may be
classified as the subacute type of AFOP. The second type
shows a more rapid progression and has clinical features
similar to that of acute respiratory distress syndrome. 
Pulmonary complications account for significant
morbidity and mortality in patients after HSCT, with an
incidence rate of 70%, and are a contributing factor in
more than 30% of transplant-related deaths [11]. With the
advances in transplantation, the reports of noninfectious
pulmonary complications have increased. However, there
are a few reports on acute-onset noninfectious pulmonary
complications following HSCT. Noninfectious pulmonary
complications are the major causes of morbidity and
mortality after allogeneic HSCT. Epidemiological data
suggest that conditioning-related toxicity is the major
contributing factor although GVHD may play a role.
Among the noninfectious pulmonary complications, obli-
terative bronchiolitis and BOOP are more closely associated
with GVHD [12]. The other complications are pulmonary
edema, engraftment syndrome, diffuse alveolar hemorrhage,
and pulmonary veno-occlusive disease [1]. 
The uniqueness of this report is that it describes
the first case of AFOP following allogeneic HSCT, and
this condition may be a type of GVHD in the lung. Further
information should be obtained about the clinical and
radiological features of AFOP and the differences between
AFOP and other acute interstitial lung disease. The present
case report provides useful data about this new entity.
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